Featured Archives

11/10/2022

7 min read

Inceptua Early Access and Sentynl Therapeutics Inc. Announce the Launch of the Early Access Program for Nulibry® (fosdenopterin)

Inceptua Early Access and Sentynl Therapeutics Inc. Announce...

Featured Press release

24/08/2022

12 min read

The Critical role of Real-World Data in Orphan Drug Development and the Role of Early Access Programs

We asked Heather Manna, VP, Global Regulatory Affairs,...

Ask Inceptua Early Access Featured

15/08/2022

8 min read

Apealea® (paclitaxel micellar) is now available in Germany for the treatment of ovarian cancer

Apealea® (paclitaxel micellar) is now available in Germany...

Featured Inceptua Pharma Press release

01/07/2022

7 min read

Early Access - bridging innovation and commercialization of therapies

This year Inceptua can celebrate its 25th anniversary....

Ask Inceptua Early Access Featured

01/04/2022

4 min read

Vice President, Global Regulatory Affairs Joins Inceptua Early Access

Vice President, Global Regulatory Affairs Joins Inceptua Early...

Featured Press release

21/01/2022

6 min read

Q&A with Mark Ware, Executive Vice President, Head of Inceptua Clinical Trial Supply

This year, Inceptua can celebrate its 25th anniversary....

World-Leading Regulatory Affairs Expert Joins Inceptua Group

World-Leading Regulatory Affairs Expert Joins Inceptua Group Luxembourg,...

Featured Press release

10/12/2021

9 min read

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer

European Commission and MHRA approves transfer of marketing...

Featured Inceptua Pharma Press release

02/12/2021

4 min read

When is an Early Access Program not the right option?

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured

10/11/2021

3 min read

Scott Forde joins Inceptua as Senior Director, Business Development.

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured Press release

07/10/2021

4 min read

Patient Forecasting in Early Access Programs

Patient Forecasting in Early Access Programs When planning...

Early Access Featured

05/10/2021

4 min read

Inceptua strengthens early access division with key business development hire

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured Press release

30/09/2021

5 min read

When Early Access Programs Go Bad

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured

28/06/2021

2 min read

Oasmia announces transfer of Nordic commercialization rights for Apealea® (Paclitaxel Micellar) to Inceptua

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Inceptua Pharma News

14/01/2021

5 min read

Is there a role for Ethics Committees in Early Access?

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Early Access Featured

28/12/2020

2 min read

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group

Lorem ipsum dolor sit amet, consectetur adipiscing elit....

Featured Inceptua Pharma Press release

Featured

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving www.inceptuapharma.com to enter the Inceptua Group website: www.inceptua.com. Links to external websites are provided as a resource to the viewer, and the content is not controlled by Inceptua Pharma.

You are about to leave!

You are now leaving an Inceptua website. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Inceptua . Inceptua accepts no responsibility for the content or services of the linked site.